ÂÜÀòÂÒÂ×

Frank Waldron-Lynch currently serves as Vice President of Cell Therapy and Immunology Research at Vertex Pharmaceuticals, emphasizing the transformative impact of science on individuals with serious diseases. In addition, Frank holds a position as a Board Member of the Eire Society of Boston, one of the city's oldest Irish organizations. Previously, Frank worked at Novartis Institutes for BioMedical Research as Director of Translational Medicine, leading efforts in autoimmunity and immunology. Academic roles include Associate Professor at the University of Cambridge and Translational Immunologist at Yale University, where expertise in immunology and translational medicine was developed. Frank's extensive education includes a Fellowship in Endocrinology and Metabolism from Yale, multiple degrees in Medicine and Experimental Medicine from prestigious institutions, and a PhD in Immunogenetics.